Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

119
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
119
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

124
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the binding of skeletal muscle myosin to fibrin in trauma.

The journal of trauma and acute care surgery·2026
Same author

A Rare Presentation of Mixed Warm and Cold Autoimmune Hemolytic Anemia.

Case reports in hematology·2026
Same author

Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials.

Advances in therapy·2026
Same author

The association between first trimester iron deficiency without anemia and the development of iron-deficiency anemia prior to childbirth.

American journal of obstetrics and gynecology·2026
Same author

Redefining Hematology Referral Thresholds for Eosinophilia.

European journal of haematology·2026
Same author

Navigating Anemia in Solid and Hematologic Malignancies: A Comprehensive Review of Classical and Emerging Therapies.

European journal of haematology·2026
Same journal

Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson's disease.

Metabolic brain disease·2026
Same journal

Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.

Metabolic brain disease·2026
Same journal

Sex-specific gut microbiota and metabolite signatures in Parkinson's disease: implications for personalized therapeutics.

Metabolic brain disease·2026
Same journal

Genetic mutations and synaptic dysfunctions in social interaction disorders: insights from invertebrate models to humans.

Metabolic brain disease·2026
Same journal

Crocin alleviates "short-term" Cadmium-induced brain and lung toxicities: investigation of key neuropeptides GLP-1 and spexin as biomarkers.

Metabolic brain disease·2026
Same journal

Electroacupuncture-modulated DHCR24 facilitates spinal cord injury recovery by attenuating apoptosis and neuroinflammation via the Wnt signaling pathway.

Metabolic brain disease·2026
See all related articles

Related Experiment Video

Updated: Nov 22, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.2K

Thrombin generation and activity in multiple sclerosis.

Kelley R Jordan1, Ivan Parra-Izquierdo2,3, András Gruber2,3,4

  • 1Department of Biomedical Engineering, Oregon Health and Science University, School of Medicine, 3303 SW Bond Avenue, Portland, OR, 97239, USA. Jordake@ohsu.edu.

Metabolic Brain Disease
|January 7, 2021
PubMed
Summary
This summary is machine-generated.

Thrombin activity, linked to blood clotting, plays a key role in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) by affecting neuro-immune responses and blood-brain barrier permeability.

Keywords:
Activated protein CExperimental autoimmune encephalomyelitisFibrinMultiple sclerosisThrombin

More Related Videos

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.0K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.2K

Related Experiment Videos

Last Updated: Nov 22, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.2K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.0K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.2K

Area of Science:

  • Neuroimmunology
  • Hematology
  • Pathophysiology

Background:

  • The coagulation cascade and immune system interact during injury and infection.
  • Hyper-coagulation is increasingly linked to autoimmune disorders like multiple sclerosis (MS).
  • MS involves immune cell activation in the central nervous system (CNS), leading to myelin damage and blood-brain barrier (BBB) breakdown.

Purpose of the Study:

  • To review evidence linking thrombin activity to the pathogenesis of MS and experimental autoimmune encephalomyelitis (EAE).
  • To explore how thrombin influences neuro-immune responses and BBB permeability in these conditions.

Main Methods:

  • Review of existing literature on thrombin's role in MS and EAE.
  • Analysis of thrombin's substrates: protease activated receptors (PARs), fibrinogen, and protein C.
  • Examination of thrombin's effects on immune regulation and BBB integrity.

Main Results:

  • Thrombin activity is evident in the CNS of MS patients.
  • Increased thrombin generation in EAE models suggests a role in disease pathogenesis and remyelination inhibition.
  • Thrombin influences neuro-immune responses and BBB permeability through PARs, fibrin formation, and protein C activation.

Conclusions:

  • Thrombin activity is a significant factor in the neuro-immune pathology of MS and EAE.
  • Understanding thrombin's mechanisms offers potential therapeutic targets for MS and related CNS disorders.